Solid Tumors
A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)
- Details
ClinicalTrials.gov ID:
NCT04083976
Diagnosis Type:
NA
USOR Number:
- Address
5050 NE Hoyt St, Suite 256
Portland, OR 97213
P: (503) 239-7767